ScholarIQanswers from OpenAlex
Instituto Nacional de Neurología y Neurocirugía
InstitutionResearch output, impact & collaborations
Instituto Nacional de Neurología y Neurocirugía is a institution indexed in ScholarIQ from OpenAlex.
What is known about Instituto Nacional de Neurología y Neurocirugía?
ScholarIQrecord summary
Instituto Nacional de Neurología y Neurocirugía is a research organisation in Mexico City, MX. OpenAlex records 6,723 works and 313,959 citations for it. 2,852 researchers list it as their most recent affiliation.
How many works does Instituto Nacional de Neurología y Neurocirugía have?
ScholarIQindexed works
Instituto Nacional de Neurología y Neurocirugía has 6,723 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Instituto Nacional de Neurología y Neurocirugía have?
ScholarIQcitation count
Instituto Nacional de Neurología y Neurocirugía has 313,959 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Instituto Nacional de Neurología y Neurocirugía?
ScholarIQresearcher count
Instituto Nacional de Neurología y Neurocirugía has 2,852 researchers in the ScholarIQ index.
What is the average h-index at Instituto Nacional de Neurología y Neurocirugía?
ScholarIQavg h-index
Instituto Nacional de Neurología y Neurocirugía has an average h-index of 16.8 in OpenAlex.
What is the ROR of Instituto Nacional de Neurología y Neurocirugía?
ScholarIQror
The ROR for Instituto Nacional de Neurología y Neurocirugía is on the source record.
What is the OpenAlex record for Instituto Nacional de Neurología y Neurocirugía?
ScholarIQopenalex
The OpenAlex for Instituto Nacional de Neurología y Neurocirugía is on the source record.
Who are the most-cited researchers behind Instituto Nacional de Neurología y Neurocirugía?
ScholarIQtop researchers by citations
What are the most-cited papers on Instituto Nacional de Neurología y Neurocirugía?
ScholarIQmost cited works
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
Robert G. Hart, Mukul Sharma, Hardi Mundl, Scott E. Kasner, Shrikant I. Bangdiwala, Scott D. Berkowitz, Balakumar Swaminathan, Pablo M. Lavados, Yongjun Wang, Yilong Wang, Antonio Dávalos, N. А. Shamalov, Robert Mikulík, Luís Cunha, Arne Lindgren, Antonio Araúz, Wilfried Lang, Anna Członkowska, Jens Eckstein, Rubens José Gagliardi, Pierre Amarenco, Sebastián F. Ameriso, Turgut Tatlisumak, Roland Veltkamp, Graeme J. Hankey, Danilo Toni, Dániel Bereczki, Shinichiro Uchiyama, George Ntaios, Byung‐Woo Yoon, Raf Brouns, Matthias Endres, Keith W. Muir, Natan M. Bornstein, Şerefnur Öztürk, Martin O’Donnell, Matthys M. De Vries Basson, Guillaume Paré, Calin Pater, Bodo Kirsch, Patrick Sheridan, Gary Peters, Jeffrey I. Weitz, W. Frank Peacock, Ashkan Shoamanesh, Oscar Benavente, Campbell Joyner, Ellison Themeles, Stuart J. Connolly
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial
Lu Ma, Xin Hu, Lili Song, Xiaoying Chen, Menglu Ouyang, Laurent Billot, Qiang Li, Alejandra Malavera, Xi Li, Paula Muñoz Venturelli, Asita de Silva, Nguyen Huy Thang, Kolawole Wahab, Jeyaraj Pandian, Mohammad Wasay, Octávio Marques Pontes‐Neto, Carlos Abanto, Antonio Araúz, Haiping Shi, Guanghai Tang, Sheng Zhu, Xiaochun She, Leibo Liu, Yuki Sakamoto, Shoujiang You, Qiao Han, Bernard Crutzen, Emily Cheung, Yunke Li, Xia Wang, Chen Chen, Feifeng Liu, Yang Zhao, Hao Li, Yi Liu, Yan Jiang, Lei Chen, Bo Wu, Ming Liu, Jianguo Xu, Chao You, C M Anderson, Thompson Robinson, J. Jaime Miranda, Craig S. Anderson, Chao You, Lili Song, Adrian Parry‐Jones, Nikola Sprigg, S. F. Durrans, Caroline Harris, Ann Bamford, Olivia Smith, Robert J. Herbert, Christopher Chen, William Whiteley, Rong Hu, Laurent Billot, Qiang Li, Jayanthi Mysore, Xin Hu, Yao Zhang, Feifeng Liu, Yuki Sakamoto, Shoujiang You, Qiao Han, Bernard Crutzen, Yunke Li, Emily Cheung, Stephen Jan, Hueiming Liu, Menglu Ouyang, Lingli Sun, Honglin Chu, Anila Anjum, Francisca Gonzalez Mc Cawley, Alejandra Del Río, Bruna Rimoli, Rodrigo Cerantola, Thanushanthan Jeevarajah, Madhushani Kannangara, Andrene Joseph, Chamath Nanayakkara, Xiaoying Chen, Alejandra Malavera, Chunmiao Zhang, Zhao Yang, Brook Li, Zhuo Meng, Menglu Ouyang, Leibo Liu, Yi Ning, Le Dong, Manuela Armenis, Joyce Lim, Helen Monaghan, Lu Ma, Xin Hu, Zhiheng Li, Rui Luo
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke
George Ntaios, Patrik Michel, Georgios Georgiopoulos, Yutao Guo, Wencheng Li, Jing Xiong, Patricia Calleja, Fernando Ostos, Guillermo González‐Ortega, Blanca Fuentes, María Alonso de Leciñana, Exuperio Díez‐Tejedor, Sebastián García‐Madrona, Jaime Masjuán, Alicia DeFelipe, Guillaume Turc, Bruno Gonçalves, Valérie Domigo, Gheorghe‐Andrei Dan, Roxana Vezeteu, Hanne Christensen, Louisa Christensen, Per Meden, Lejla Hajdarevic, Ángela Rodríguez‐López, Fernando Díaz‐Otero, Á. García Pastor, Antonio Gil-Núñez, Errikos Maslias, Davide Strambo, David J. Werring, Arvind Chandratheva, Laura Benjamin, Robert Simister, Richard Perry, Rahma Beyrouti, Pascal Jabbour, Ahmad Sweid, Stavropoula Tjoumakaris, Elisa Cuadrado‐Godia, Ana Rodríguez-Campello, Jaume Roquer, Tiago Moreira, Michael V. Mazya, Fabio Bandini, Karl Matz, Helle K. Iversen, Alejandra González‐Duarte, Cristina Tiu, Julia Ferrari, Milan R. Voško, Helmut J.F. Salzer, Bernd Lamprecht, Martin W. Dünser, Carlo W. Cereda, Ángel Basilio Corredor-Quintero, Eleni Korompoki, Eduardo Soriano-Navarro, Luis Enrique Soto-Ramírez, Paulo Castañeda-Méndez, Daniela Bay-Sansores, Antonio Araúz, Vanessa Cano-Nigenda, Espen Saxhaug Kristoffersen, Marjaana Tiainen, Daniel Strbian, Jukka Putaala, Gregory Y.H. Lip
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados, Mukul Sharma, Keith W. Muir, Roland Veltkamp, Sebastián F. Ameriso, Matthias Endres, Helmi L. Lutsep, Steven R. Messé, J. David Spence, Krassen Nedeltechev, Kanjana Perera, Gustavo Santo, Verónica V. Olavarría, Arne Lindgren, Shrikant I. Bangdiwala, Ashkan Shoamanesh, Scott D. Berkowitz, Hardi Mundl, Stuart J. Connolly, Robert G. Hart, Noureldin Abdelhamid, Durdana Rahman, Mudhar Abdul-Saheb, Pedro Abreu, M V Abroskina, Faraz Ahmad, Sandrine Accassat, Monica Acciaresi, Alessandro Adami, Noor-Us-Sabah Ahmad, Farhat Ahmed, M Alberto Hawkes, Fana Alemseged, Asad Ali, Riccardo Altavilla, L Alwis, Pierre Amarenco, Sergio Amaro, LE Amaya Sanchez, A Amelia Pinto, SF Ameriso, Haitham Amin, T. Amino, AK Amjad, E. Anagnostou, Grethe Andersen, Craig S. Anderson, DC Anderson, M Andrea Falco, Frances MacKinnon, David Andreu, Michael Androulakis, Miguel Ángel Gamero-García, G Angel Saredo, Rafael Díaz, M Angels Font, Sabrina Anticoli, Antonio Araúz, AA Arauz Gongora, P. Araya, J. Arenillas Lara, Susana Arias-Rivas, Marcel Arnold, Salvador Augustín, Wagner Mauad Avelar, Elsa Azevedo, Viken L. Babikian, Aroldo Bacellar, K R Badalyan, HJ Bae, Eric A. Martínez, H Bagelmann, Peter Bailey, Zoltán Bak, Mitchell B. Baker, Alejandro B. Balazs, Dobri Baldaranov, Ibrahim Balogun, T V Balueva, Z Bankuti, Michal Bar, Anna Baranowska, Juergen Bardutzky, S Barker Trejo, Jessica Barlinn, Flore Baronnet, C. García Barroso, M Barteys, T Bartolottiova, А. Е. Барулин, M. Baş, Saima Bashir, Vincenzo S. Basile, R. Bathe-Peters, Raj Bathula, César V.F. Batista, Hale Zeynep Batur Çağlayan, Philipp Baumgartner
Regulatory impairment in untreated Parkinson’s disease is not restricted to Tregs: other regulatory populations are also involved
Diana Denisse Álvarez‐Luquín, Asiel Arce-Sillas, Jaquelín Leyva-Hernández, Edgar Sevilla-Reyes, Marie‐Catherine Boll, Esteban Uriel Montes-Moratilla, Viridiana Vivas-Almazán, Citzielli Aseret Pérez-Correa, Ulises Rodríguez-Ortiz, Raquel Espinoza-Cárdenas, Gladis Fragoso, Edda Sciutto, Laura Adalid‐Peralta
How much of the research on Instituto Nacional de Neurología y Neurocirugía is open access?
ScholarIQopen access share
67%OPEN ACCESS